Alberta Doctor’s Cancer Coaching Ban Upheld After Appeal Rejection
A former Alberta doctor has been ordered for a second time to cease providing unlicensed medical advice online after an appeal court rejected his latest challenge, according to documents filed in the Alberta Court of Queen’s Bench. Dr. Leila Hoteit, a physician who has faced multiple regulatory actions for promoting unproven cancer treatments, now faces potential disciplinary measures from the College of Physicians and Surgeons of Alberta (CPSA) as the legal battle escalates.
The court’s decision on May 15, 2024, upholds a 2023 injunction that barred Hoteit from engaging in “cancer coaching”—a term used to describe her practice of offering personalized medical advice to patients without proper licensing or oversight. The CPSA, which regulates medical professionals in Alberta, had previously suspended Hoteit’s license in 2022 after finding she had violated ethical standards by diagnosing and treating patients remotely without a valid practice agreement. Despite the suspension, Hoteit continued to operate through social media platforms and a website, CancerCoaching.com, where she charged fees for consultations.
Why was Hoteit’s appeal rejected?
The Alberta Court of Queen’s Bench rejected Hoteit’s appeal on procedural grounds, ruling that her legal team had failed to meet deadlines for filing necessary documentation. According to court filings reviewed by the CBC, Hoteit’s lawyers argued that the original injunction was overly broad and infringed on her right to free speech. However, Justice Brian Gorsky dismissed these claims, stating that the restrictions were justified under Alberta’s Health Professions Act, which prohibits unlicensed medical practice.
Legal experts consulted by the Globe and Mail described the ruling as a victory for patient safety, noting that unregulated medical advice—particularly in high-stakes areas like oncology—poses significant risks. “The court’s decision reinforces that medical practice requires both a license and adherence to professional standards,” said Dr. David Barnard, a health law professor at the University of Calgary. “Patients deserve care that is evidence-based and delivered by qualified professionals.”
What happens next for Hoteit and the CPSA?
The CPSA has indicated it will now proceed with disciplinary hearings, which could result in further sanctions, including an extended suspension or permanent revocation of Hoteit’s medical license. In a statement to World Today News, a CPSA spokesperson confirmed that the college is reviewing the court’s decision and preparing for the next phase of proceedings. “Our priority remains protecting the public from unlicensed and potentially harmful medical advice,” the spokesperson said.
Hoteit’s legal team has not yet announced whether they will pursue further appeals, though sources close to the case suggest they may explore constitutional challenges under Alberta’s freedom of expression laws. Meanwhile, the CPSA has ramped up monitoring of online platforms where unlicensed medical advice is disseminated, collaborating with provincial health authorities to identify and shut down rogue practitioners.
How does this case compare to other regulatory crackdowns?
Hoteit’s situation mirrors that of other physicians in Canada and the U.S. who have faced disciplinary action for operating outside traditional healthcare systems. In 2023, the New England Journal of Medicine published a case study highlighting a surge in “telemedicine fraud,” where unlicensed practitioners exploit loopholes in digital health regulations. Unlike Hoteit, who targeted cancer patients, some cases involved practitioners offering unproven treatments for chronic conditions like diabetes or autoimmune disorders.
Alberta’s approach differs from some U.S. states, where regulatory bodies have struggled to enforce jurisdiction over online medical advice due to interstate commerce laws. However, Canada’s provincial healthcare model allows for tighter control, as seen in British Columbia, where a similar case against a naturopath resulted in a $50,000 fine for practicing without a license. The CPSA’s aggressive stance in Hoteit’s case suggests Alberta is taking a harder line than some peers.
What risks do patients face from unlicensed “cancer coaching”?
Health Canada and the Canadian Cancer Society have warned that unregulated cancer treatments—such as those promoted by Hoteit—can delay evidence-based care and expose patients to experimental or dangerous therapies. A 2022 report by the Journal of Clinical Oncology found that patients who consulted unlicensed practitioners were twice as likely to forgo standard treatments like chemotherapy or radiation in favor of alternative therapies.
Hoteit’s platform, which advertised “personalized cancer protocols” for fees ranging from $200 to $1,500 per consultation, has been a focal point of criticism. While she has claimed her methods are rooted in “integrative medicine,” the CPSA and oncologists argue that her lack of affiliation with accredited hospitals or research institutions undermines her credibility. “When a patient with cancer seeks advice, they deserve access to treatments that have been rigorously tested, not anecdotal claims,” said Dr. Linda Duska, president of the Canadian Association of Radiation Oncology.
The case also raises broader questions about how digital health platforms—many of which operate with minimal oversight—enable unlicensed practitioners to reach vulnerable audiences. A 2023 investigation by the Toronto Star found that Facebook and Instagram ads for unproven cancer cures had surged by 40% since 2020, often bypassing platform moderation policies. Alberta’s legal action against Hoteit may set a precedent for other provinces to crack down on similar operations.
For now, the focus remains on the CPSA’s next steps. With no immediate appeals process left, Hoteit’s future in medicine hangs in the balance—as does the fate of her online empire, which has drawn scrutiny from both regulators and patient advocacy groups.